UK should screen for tyrosinaemia in newborn babies, committee recommendsBMJ 2023; 380 doi: https://doi.org/10.1136/bmj.p275 (Published 02 February 2023) Cite this as: BMJ 2023;380:p275
View Full Text
- Gareth Iacobucci
- The BMJ
The UK National Screening Committee has recommended screening for tyrosinaemia in babies as part of the newborn blood spot screening programme in the four UK nations.
Tyrosinaemia type 1 (TYR1) is a rare genetic condition that prevents the body from breaking down a substance called tyrosine found in food—causing damage to the liver, kidneys, and the nervous system if untreated.
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.